Whitehawk Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $27.2M | $132.4M | $62.9M |
| FY2024 | $17.8M | $70.3M | $28.7M |
| FY2025 | $14.5M | $150.8M | $37.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $27.2M | $132.4M | $62.9M |
| FY2024 | $17.8M | $70.3M | $28.7M |
| FY2025 | $14.5M | $150.8M | $37.6M |